Calving intervals of beef cows treated with either gonadotrophin releasing hormone or a progesterone releasing intravaginal device

1982 ◽  
Vol 110 (22) ◽  
pp. 515-517 ◽  
Author(s):  
A. Peters
2020 ◽  
Vol 32 (2) ◽  
pp. 209
Author(s):  
L. Pfeifer ◽  
J. Andrade ◽  
E. Moreira ◽  
G. Silva ◽  
V. Souza ◽  
...  

The aims of this study were to determine (1) the association between Doppler vascularisation scores (DVS) of the preovulatory follicle (POF) and fertility of beef cows submitted to timed AI (TAI) and (2) whether cows with low DVS benefit from a gonadotrophin-releasing hormone (GnRH) treatment at TAI. Multiparous lactating Nelore cows (Bos indicus; n=69) from a commercial beef farm in the state of Rondônia, Brazil, were enrolled in this study. Cows received 2mg of oestradiol benzoate intramuscularly (Bioestrogen, Biogénesis Bagó) and an intravaginal progesterone-releasing device (1.9g of progesterone; controlled internal drug release, CIDR) to synchronise follicular wave emergence on Day 0. The CIDR device was removed and cows were treated with 150μg of D-cloprostenol intramuscularly (prostaglandin F2α analogue; Croniben), 1mg of oestradiol cypionate intramuscularly, and 300IU of equine chorionic gonadotrophin (Novormon) intramuscularly on Day 8. Cows were then painted with a tail chalk marker to identify those displaying oestrus. All cows were submitted to TAI 48h after CIDR removal. At TAI, occurrence of oestrus was recorded and all cows were examined using transrectal ultrasonography. Blood flow of the POF was evaluated using colour Doppler imaging. Colour Doppler signals present on the follicular wall were subjectively scored using a 1-to-4 scale (1=absence or very low blood flow, and 4=intense blood flow detected on most of the follicular wall surface) adapted from Ginther (2007Ultrasonic Imaging and Animal Reproduction: Color-Doppler Ultrasonography, pages 87-114). Then, cows were divided into three groups according their DVS of the POF: (1) high DVS (DVS ≥3; n=36), (2) low DVS (DVS <3; n=16), and (3) low DVS (DVS <3; n=17) plus a GnRH treatment at TAI. The diameter of the POF was analysed using analysis of variance (PROC GLIMMIX of SAS; SAS Institute Inc.), and the means were compared among groups using Tukey's test. The proportion of cows that displayed oestrus and pregnancy rates was analysed using chi-square test. Cows in the high-DVS group had a larger POF than cows in the low-DVS and low-DVS-GnRH groups (13.2±0.2, 11.7±0.5, and 12.2±0.4, respectively; P<0.05). The proportion of cows that displayed oestrus was greater (P<0.05) in the high-DVS group (72%, 26/36) than in the low-DVS (37.5%, 6/16) or low-DVS-GnRH (53%, 9/17) groups. Finally, greater (P<0.05) pregnancy rates were observed in cows from the high-DVS (47.2%; 17/36) and low-DVS-GnRH (52.9%; 9/17) groups than in cows from the low-DVS group (18.7%; 3/16). The preliminary results from this study demonstrated that diameter of POF is positively associated with DVS. Moreover, cows that presented POF with higher DVS are more likely to become pregnant, and the administration of GnRH to females with low DVS can increase the fertility of beef cows submitted to TAI protocols. This study received funding support from Embrapa (MP1/PC3 project no. 01.03.14.011.00.00) and from CNPq (universal project no. 407307/2016-8).


2020 ◽  
Vol 32 (2) ◽  
pp. 208
Author(s):  
A. Butler ◽  
H. Butler ◽  
G. Cesaroni ◽  
R. Alberio ◽  
S. Perez Wallace ◽  
...  

Oestrus expression between progesterone (P4) withdrawal and fixed-time AI (FTAI) has been shown to improve pregnancies per AI (P/AI) by 27% in beef cattle. As a result, cattle that do not express oestrus after P4 withdrawal present a challenge to the efficiency of FTAI. The present study was designed to test the hypothesis that administration of gonadotrophin-releasing hormone (GnRH) at the time of AI in heifers that do not express oestrus can improve fertility. Two-year-old Angus heifers (n=1032) with a condition score of 2.75 to 3.5 at two locations in Argentina were used. On Day 0, heifers received an intravaginal device containing 0.5g of P4 (Cronipres, Biogenesis) and 2mg of oestradiol benzoate intramuscularly (Bioestrogen, Biogenesis). On Day 8, devices were removed and heifers received 150µg of d-cloprostenol intramuscularly (Enzaprost, Biogenesis), 0.5mg of oestradiol cipionate intramuscularly (Croni-Cip, Biogenesis), and an oestrus detection patch (Estrotect, Rockway Inc.). On Day 10, AI was performed in all heifers 50 to 54h after device removal. Heifers were categorised based on oestrus expression, and those that did not express oestrus were randomised to receive 100µg of gonadorelin acetate intramuscularly (Gonasyn, Syntex; n=158) concurrent with AI or remain as untreated controls (n=151). Pregnancy was determined using ultrasonography at Days 38 and 111 after AI. Differences in fertility were evaluated using generalised linear mixed models, and the results are shown in Table 1. Oestrus expression between device removal and FTAI was 70.1% (723/1032). Pregnancies per AI at Days 38 and 111 were different between groups (P<0.01). Heifers that expressed oestrus had greater P/AI than those that did not regardless of treatment (P<0.01). However, in heifers that did not express oestrus, treatment with GnRH at the time of AI resulted in greater P/AI than in control heifers (P=0.004). Similarly, P/AI at Day 111 were greater in heifers that expressed oestrus than in those that did not regardless of treatment (P<0.01). Heifers that did not express oestrus and were treated with GnRH had greater P/AI than those that did not express oestrus and remained as controls (P=0.02). Pregnancy loss between Days 38 and 111 was not different between groups; however, there was a tendency (P=0.06) for greater pregnancy loss in heifers that did not express oestrus and were treated with GnRH compared with heifers that expressed oestrus. In summary, treatment with GnRH at the time of AI is a suitable strategy to improve P/AI in heifers that fail to exhibit oestrus after an oestradiol-based synchronisation protocol. However, this strategy appears to increase pregnancy loss, and thus further research is needed to confirm this observation and the mechanisms underlying it. Table 1.Pregnancies per AI (P/AI) and pregnancy loss (%; no. in parentheses) in Angus heifers based on oestrus expression and treatment with GnRH Group P/AI Day 38 P/AI Day 111 Pregnancy loss Oestrus 68.9 (498/723)A 65.2 (471/723)A 5.4 (27/498) No oestrus control 29.8 (45/151)B 28.5 (43/151)B 4.4 (2/45) No oestrus + GnRH 45.6 (72/158)C 40.5 (64/158)C 11.1 (8/72) P-value <0.001 <0.001 0.15 A-CValues within a column with different superscripts differ significantly (P<0.05).


1996 ◽  
Vol 1996 ◽  
pp. 67-67
Author(s):  
Duncan Pullar ◽  
Anthony Wrathall

Use of the gonadotrophin releasing hormone (GnRH) analogue, buserelin has been shown to be effective reducing embryo mortality, by a luteoprotective mechanism, in reproductively normal dairy cows. Drew and Peters, (1991) increased mean pregnancy rates to AI from 53.4 to 65.4% in dairy herds by a buserelin treatment, given 10-12 post service. The objective of this experiment was to determine whether buserelin can also have a beneficial effect on pregnancy rate, in normal and known problem suckler cows.Seventy-eight Hereford x Friesian cows (from 0-4 parities) were used. Forty were considered reproductively normal ('normal' cows) having calved each year from their first season and currently with a 10 week old calf at-foot; while 38 had a history of reproductive disorders ('suspect' cows) and had not calved in the previous 15 months (May 1994 to July 1995).


1996 ◽  
Vol 1996 ◽  
pp. 67-67
Author(s):  
Duncan Pullar ◽  
Anthony Wrathall

Use of the gonadotrophin releasing hormone (GnRH) analogue, buserelin has been shown to be effective reducing embryo mortality, by a luteoprotective mechanism, in reproductively normal dairy cows. Drew and Peters, (1991) increased mean pregnancy rates to AI from 53.4 to 65.4% in dairy herds by a buserelin treatment, given 10-12 post service. The objective of this experiment was to determine whether buserelin can also have a beneficial effect on pregnancy rate, in normal and known problem suckler cows.Seventy-eight Hereford x Friesian cows (from 0-4 parities) were used. Forty were considered reproductively normal ('normal' cows) having calved each year from their first season and currently with a 10 week old calf at-foot; while 38 had a history of reproductive disorders ('suspect' cows) and had not calved in the previous 15 months (May 1994 to July 1995).


Sign in / Sign up

Export Citation Format

Share Document